دورية أكاديمية
أعرض في EDS

Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma.

التفاصيل البيبلوغرافية
العنوان: Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma.
المؤلفون: Bosma SE; Department of Orthopedics, Leiden University Medical Center, The Netherlands., van Driel PB; Department of Orthopedics, Leiden University Medical Center, The Netherlands., Hogendoorn PC; Department of Pathology, Leiden University Medical Center, The Netherlands., Dijkstra PS; Department of Orthopedics, Leiden University Medical Center, The Netherlands., Sier CF; Department of Surgery, Leiden University Medical Center, The Netherlands.
المصدر: Journal of surgical oncology [J Surg Oncol] 2018 Nov; Vol. 118 (6), pp. 906-914. Date of Electronic Publication: 2018 Sep 13.
نوع المنشور: Journal Article; Review; Systematic Review
اللغة: English
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE
أسماء مطبوعة: Publication: <2005-> : Hoboken, NJ : Wiley-Liss
Original Publication: New York, Plenum.
مواضيع طبية MeSH: Bone Neoplasms/*diagnostic imaging , Bone Neoplasms/*surgery , Optical Imaging/*methods , Orthopedic Procedures/*methods , Sarcoma, Ewing/*diagnostic imaging , Sarcoma, Ewing/*surgery, Biomarkers, Tumor/metabolism ; Bone Neoplasms/metabolism ; Humans ; Monitoring, Intraoperative/methods ; Sarcoma, Ewing/metabolism
مستخلص: Ewing sarcoma (ES), an aggressive bone and soft-tissue tumor, is treated with chemotherapy, radiotherapy, and surgery. Intra-operative distinction between healthy and tumorous tissue is of paramount importance but challenging, especially after chemotherapy and at complex anatomical locations. Near infrared (NIR) fluorescence-guided surgery (FGS) is able to facilitate the determination of tumor boundaries intra-operatively, improving complete resection and therefore survival. This review evaluates potential ES-specific proteins from the literature as targets for NIR FGS.
(© 2018 The Authors. Journal of Surgical Oncology Published by Wiley Periodicals, Inc.)
References: Adv Drug Deliv Rev. 2014 Sep 30;76:21-38. (PMID: 25064553)
Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):3603-8. (PMID: 26979953)
J Pathol. 2011 Nov;225(3):353-63. (PMID: 21984123)
Cancer Res. 1996 Oct 15;56(20):4570-4. (PMID: 8840962)
PLoS One. 2016 Jan 05;11(1):e0146504. (PMID: 26731105)
J Pharmacol Exp Ther. 2014 Jul;350(1):110-23. (PMID: 24756303)
Clin Cancer Res. 2010 Jul 15;16(14):3769-78. (PMID: 20525755)
Gut. 2018 Apr;67(4):736-745. (PMID: 28360099)
Nat Med. 2011 Sep 18;17(10):1315-9. (PMID: 21926976)
Oncogene. 2006 May 4;25(19):2795-800. (PMID: 16314831)
Clin Cancer Res. 2017 May 15;23(10):2565-2574. (PMID: 27815356)
Lancet Oncol. 2017 Nov;18(11):1493-1501. (PMID: 28988646)
Int J Biomed Imaging. 2012;2012:940585. (PMID: 22577366)
Am J Surg Pathol. 2002 Apr;26(4):486-92. (PMID: 11914627)
Eur J Cancer. 2016 Jul;61:128-36. (PMID: 27176931)
Virchows Arch. 2014 Nov;465(5):599-605. (PMID: 25031013)
Surg Oncol. 2016 Mar;25(1):16-23. (PMID: 26979636)
Biomark Cancer. 2016 Sep 27;8:119-133. (PMID: 27721658)
CNS Drugs. 2013 Jul;27(7):493-503. (PMID: 23681979)
Blood. 2006 Mar 15;107(6):2223-33. (PMID: 16291593)
J Clin Oncol. 2000 Sep;18(17):3108-14. (PMID: 10963639)
Virchows Arch. 2012 Sep;461(3):333-7. (PMID: 22898789)
Peptides. 2007 Feb;28(2):419-25. (PMID: 17223228)
Am J Med. 1999 Apr;106(4):467-76. (PMID: 10225251)
Nat Neurosci. 2004 Mar;7(3):221-8. (PMID: 14966521)
Pediatr Blood Cancer. 2012 Apr;58(4):532-8. (PMID: 21994054)
J Surg Oncol. 2015 Jul;112(1):2-8. (PMID: 26074273)
Mod Pathol. 2005 Nov;18(11):1403-10. (PMID: 15920547)
Med Pediatr Oncol. 1999 Mar;32(3):186-95. (PMID: 10064186)
Nat Rev Clin Oncol. 2013 Sep;10(9):507-18. (PMID: 23881033)
Clin Oncol (R Coll Radiol). 2013 Jan;25(1):19-26. (PMID: 22917543)
Clin Sarcoma Res. 2012 Dec 18;2(1):24. (PMID: 23249693)
Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):169-77. (PMID: 23527719)
Oncogene. 2011 Jun 16;30(24):2730-40. (PMID: 21278796)
Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):766-72. (PMID: 16626886)
Clin Orthop Relat Res. 2007 Jun;459:40-7. (PMID: 17414166)
Int J Mol Sci. 2015 Jul 16;16(7):16176-215. (PMID: 26193259)
J Pediatr Orthop. 2008 Jan-Feb;28(1):29-35. (PMID: 18157043)
J Pediatr Hematol Oncol. 2008 Jun;30(6):425-30. (PMID: 18525458)
Mol Imaging. 2017 Jan-Dec;16:1536012117736648. (PMID: 29169312)
Nat Rev Cancer. 2013 Sep;13(9):653-62. (PMID: 23924645)
J Surg Oncol. 2018 Nov;118(6):906-914. (PMID: 30212597)
Clin Cancer Res. 2014 Feb 1;20(3):678-87. (PMID: 24218512)
Cell Mol Gastroenterol Hepatol. 2015 Dec 13;2(2):222-237. (PMID: 27840845)
Cancer Treat Rev. 2010 Jun;36(4):342-7. (PMID: 20223595)
Transl Oncol. 2011 Apr 01;4(2):71-82. (PMID: 21461170)
Target Oncol. 2013 Dec;8(4):253-60. (PMID: 23292309)
Clin Cancer Res. 2008 Aug 15;14(16):5043-9. (PMID: 18698022)
Ann Oncol. 2013 Mar;24(3):784-91. (PMID: 23104723)
J Biol Chem. 2006 Nov 24;281(47):36378-90. (PMID: 17005555)
J Clin Oncol. 2015 Sep 20;33(27):3036-46. (PMID: 26304893)
Cancer. 1996 Aug 15;78(4):892-900. (PMID: 8756387)
Saudi Med J. 2005 Aug;26(8):1190-6. (PMID: 16127511)
Clin Oncol (R Coll Radiol). 2014 Nov;26(11):722-9. (PMID: 24919857)
Curr Pharm Biotechnol. 2013;14(4):449-63. (PMID: 22335486)
BMC Cancer. 2017 May 26;17(1):383. (PMID: 28549419)
World J Orthop. 2016 Sep 18;7(9):527-38. (PMID: 27672565)
Head Neck Pathol. 2018 Mar;12(1):89-94. (PMID: 28616785)
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S693-700. (PMID: 23943029)
Br J Cancer. 2009 Jul 7;101(1):71-9. (PMID: 19491901)
Mod Pathol. 2016 Apr;29(4):370-80. (PMID: 26847175)
Clin Cancer Res. 2013 Jul 15;19(14):3745-54. (PMID: 23674494)
Curr Drug Targets. 2010 Jun;11(6):745-51. (PMID: 20041844)
J Clin Epidemiol. 2009 Oct;62(10):1006-12. (PMID: 19631508)
J Nucl Med. 2016 May;57(5):741-6. (PMID: 26769866)
Am J Surg Pathol. 2012 Jul;36(7):993-9. (PMID: 22446943)
Nat Neurosci. 2005 Jun;8(6):745-51. (PMID: 15895088)
Biomaterials. 2017 Feb;116:106-117. (PMID: 27914983)
فهرسة مساهمة: Keywords: CD99; CXCR4; Ewing sarcoma (ES); Image guided surgery; LINGO-1; cell surface targets
المشرفين على المادة: 0 (Biomarkers, Tumor)
تواريخ الأحداث: Date Created: 20180914 Date Completed: 20181119 Latest Revision: 20210109
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC6220824
DOI: 10.1002/jso.25224
PMID: 30212597
قاعدة البيانات: MEDLINE
الوصف
تدمد:1096-9098
DOI:10.1002/jso.25224